Alyeska Investment Group, L.P. Zai Lab LTD Transaction History

Alyeska Investment Group, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $2.08 Million - $4.47 Million	-90,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $2.08 Million - $4.83 Million	75,000 Added 500.0%	90,000 $3.96 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $109,086 - $209,052	1,987 Added 15.27%	15,000 $943,000
Q4 2019 Feb 14, 2020	SELL	$29.79 - $43.06 $1.6 Million - $2.31 Million	-53,594 Reduced 80.46%	13,013 $541,000
Q2 2019 Aug 14, 2019	SELL	$25.73 - $35.79 $25,549 - $35,539	-993 Reduced 1.47%	66,607 $0
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $1.05 Million - $1.49 Million	58,840 Added 671.69%	67,600 $1.32 Million
Q2 2018 Aug 14, 2018	SELL	$18.0 - $25.01 $93,852 - $130,402	-5,214 Reduced 37.31%	8,760 $204,000
Q1 2018 May 15, 2018	SELL	$20.05 - $26.96 $2.05 Million - $2.75 Million	-102,181 Reduced 87.97%	13,974 $298,000
Q4 2017 Feb 14, 2018	BUY	$21.23 - $34.09 $342,970 - $550,723	16,155 Added 16.16%	116,155 $2.47 Million
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $2.7 Million - $3.11 Million	100,000	100,000 $2.7 Million

122

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.67B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.